TRADING UPDATES: Cambria Automobiles suitor tables improved offer
TRADING UPDATES: Cambria Automobiles suitor tables improved offer
Read moreFri, 21st Feb 2020 11:53
TRADING UPDATES: Cambria Automobiles suitor tables improved offer
Read more(Sharecast News) - Cell engineering technology company MaxCyte announced the pricing of its upsized offering of 13,500,000 shares on Nasdaq on Friday, at a price of $13.00 per share.
Read moreTRADING UPDATES: Attraqt and tinyBuild trade in line in first half
Read moreIN BRIEF: MaxCyte makes administrative changes ahead of Nasdaq listing
Read moreUK shareholder meetings calendar - next 7 days
Read moreEXECUTIVE CHANGES: Keywords Studies CEO Day retires after 12 years
Read moreTRADING UPDATES: Bank of Cyprus outlook hinges on tourism industry
Read more(Sharecast News) - Cell-based therapy developer MaxCyte announced the signing of a strategic platform licence with clinical-stage biotechnology company Celularity on Tuesday.
Read moreIN BRIEF: MaxCyte prepares for listing in New York
Read more(Sharecast News) - Cell engineering technology company MaxCyte has submitted a draft registration statement with the Securities and Exchange Commission (SEC), it announced on Friday, for a proposed dual-listing and public offering of shares on the Nasdaq market.
Read moreIN BRIEF: MaxCyte to consolidate two lines of common stock into one
Read more(Sharecast News) - Cell engineering company MaxCyte announced the consolidation of two of its lines of common stock into a single unrestricted line of common stock on Thursday.
Read moreTRADING UPDATES: Zegona profit sinks; Flowtech Fluidpower suffers loss
Read more(Sharecast News) - Cell engineering technology company MaxCyte reported a 21% year-on-year improvement in revenues in its final results on Tuesday, to $26.2m (£18.74m), despite the challenges of the Covid-19 pandemic.
Read more(Sharecast News) - Cell engineering and life sciences company MaxCyte has announced a subscription to raise £40m, in a bid to strengthen its balance sheet.
Read more